文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

大语言模型自动生成宫颈癌放疗计划的可行性研究

Feasibility study of automatic radiotherapy treatment planning for cervical cancer using a large language model.
PubMed 文献 · Radiat Oncol · 2025-05-15

本研究评估大语言模型(LLM)自动优化宫颈癌VMAT放疗计划的能力,使用35例患者数据,在5例上调优后于30例上测试。Qwen-2.5-max与Llama-3.2均可在短于人工物理师约20分钟的时间内生成可接受的计划,靶区适形性与OAR保护与人工计划相近。

要点

  • Qwen-2.5-max与Llama-3.2生成可接受VMAT计划的时间分别为16.3±5.0和9.8±2.1分钟,快于人工约20分钟。
  • LLM计划与人工计划的OAR剂量保护无显著差异,靶区适形性存在显著差异。
  • Qwen-2.5-max与Llama-3.2在PTV剂量、OAR保护及靶区适形性上无统计学显著差异。

核心结论

  • LLM生成的宫颈癌VMAT计划在靶区适形性和OAR剂量保护上与人工计划相当,初步支持LLM用于自动优化放疗计划的可行性。

研究设计与样本

  • 采用35例接受VMAT治疗的宫颈癌患者数据集,对多种LLM调整优化参数。
  • 在5例患者上使用定制提示词调优LLM,随后在30例患者上测试。
  • 比较LLM生成计划与人工计划在靶区适形性、剂量均匀性、MU值及OAR剂量保护上的差异。

主要发现

  • Qwen-2.5-max与Llama-3.2分别用16.3±5.0和9.8±2.1分钟生成可接受的VMAT计划,人工物理师约需20分钟。
  • 测试集上Qwen-2.5-max、Llama-3.2和人工计划的平均CI分别为0.929±0.007、0.928±0.007和0.926±0.007。
  • 平均HI分别为0.058±0.006、0.059±0.005和0.065±0.006。
  • LLM计划与人工计划在靶区适形性上存在显著差异,OAR剂量保护无显著差异。
  • Qwen-2.5-max与Llama-3.2计划在PTV剂量、OAR剂量保护和靶区适形性上无统计学显著差异。

关键数值与推荐

  • 除Gemini-1.5-flash因幻觉问题外,Qwen-2.5-max和Llama-3.2均能生成可接受的VMAT计划。

临床怎么用

  • LLM有望用于自动优化宫颈癌VMAT计划,缩短计划时间并减轻物理师工作量。
  • 临床使用时需注意不同LLM表现差异,Gemini-1.5-flash因幻觉问题不适用。

局限性

  • 研究仅纳入35例宫颈癌患者,样本量有限。
  • 仅评估了部分LLM,且Gemini-1.5-flash因幻觉问题未能生成可接受计划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radiotherapy treatment planning traditionally involves complex and time-consuming processes, often relying on trial-and-error methods. The emergence of artificial intelligence, particularly Large Language Models (LLMs), surpassing human capabilities and existing algorithms in various domains, presents an opportunity to automate and enhance this optimization process. PURPOSE: This study seeks to evaluate the capacity of LLMs to generate radiotherapy treatment plans comparable to those crafted by human medical physicists, focusing on target volume conformity and organs-at-risk (OARs) dose sparing. The goal is to automate the optimization process of radiotherapy treatment plans through the utilization of LLMs. METHODS: Multiple LLMs were employed to adjust optimization parameters for radiotherapy treatment plans, using a dataset comprising 35 cervical cancer patients treated with volumetric modulated arc therapy (VMAT). Customized prompts were applied to 5 patients to tailor the LLMs, which were subsequently tested on 30 patients. Evaluation metrics included target volume conformity, dose homogeneity, monitor units (MU) value, and OARs dose sparing, comparing plans generated by various LLMs to manual plans. RESULTS: With the exception of Gemini-1.5-flash, which faced challenges due to hallucinations, Qwen-2.5-max and Llama-3.2 produced acceptable VMAT plans in 16.3 ± 5.0 and 9.8 ± 2.1 min, respectively, outperforming an experienced human physicist's time cost of about 20 min. The average conformity index (CI) for Qwen-2.5-max plans, Llama-3.2 plans, and manual plans on the test set were 0.929 ± 0.007, 0.928 ± 0.007, and 0.926 ± 0.007, respectively. The average homogeneity index (HI) was 0.058 ± 0.006, 0.059 ± 0.005, and 0.065 ± 0.006, respectively. While there was a significant difference in target volume conformity between LLM plans and manual plans, OARs dose sparing showed no significant variations. In lateral comparisons among different LLMs, no statistically significant differences were observed in the PTV dose, OARs dose sparing, and target volume conformity between Qwen-2.5-max and Llama-3.2 plans. CONCLUSIONS: Through an assessment of LLM-generated plans and clinical plans in terms of target volume conformity and OARs dose sparing, this study provides preliminary evidence supporting the viability of LLMs for optimizing radiotherapy treatment plans. The implementation of LLMs demonstrates the potential for enhancing clinical workflows and reducing the workload associated with treatment planning.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Wei S, Hu A, Liang Y, et al. Feasibility study of automatic radiotherapy treatment planning for cervical cancer using a large language model. Radiat Oncol. 2025. PMID: 40375332. doi:10.1186/s13014-025-02660-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。